What is the recommended treatment for postpartum hemorrhage (PPH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Postpartum Hemorrhage (PPH)

The recommended first-line treatment for postpartum hemorrhage is immediate administration of oxytocin 5-10 IU slow IV or intramuscular injection, followed by tranexamic acid 1g IV within 3 hours of bleeding onset if bleeding continues. 1, 2

Initial Assessment and Management

  1. Establish IV access immediately to ensure medication administration and fluid resuscitation 1

  2. Administer oxytocin as first-line treatment:

    • 5-10 IU slow IV or intramuscular injection 2, 3
    • For ongoing hemorrhage, higher infusion doses (up to 80 IU/500 mL) appear more effective than lower doses 4
    • IV administration is superior to IM for management of PPH 5
  3. Identify the cause using the Four T's mnemonic:

    • Tone: Uterine atony (most common cause, >75% of cases) 2
    • Trauma: Lacerations, hematoma, uterine rupture
    • Tissue: Retained placental fragments
    • Thrombin: Coagulopathy

Escalating Treatment Algorithm

For Uterine Atony (First-line interventions)

  1. Uterine massage and continued oxytocin 2, 1
  2. Tranexamic acid 1g IV within 1-3 hours of bleeding onset 2, 1
    • Reduces maternal mortality when given within this timeframe
    • Should not be delayed while waiting for other interventions

Second-line Interventions

  1. Additional uterotonics if bleeding continues:

    • Carboprost tromethamine (15-methyl PGF2α) 250 μg IM, may repeat every 15-90 minutes (maximum 8 doses/2mg) 6
    • Avoid prostaglandin F2α in women with asthma as it may cause bronchoconstriction 2
    • Avoid ergometrine in women with hypertension or asthma 2, 1
  2. Blood product administration if significant bleeding continues:

    • If coagulation tests are not known, withhold FFP until four units of RBC have been given 2
    • After four units of RBC, give four units of FFP and maintain 1:1 ratio until coagulation results are available 2
    • Monitor fibrinogen levels - a level <2 g/L with ongoing bleeding requires fibrinogen replacement 2

Third-line Interventions

  1. Imaging and interventional procedures:

    • CT with IV contrast or CTA to identify bleeding source if conventional treatment fails 2
    • Consider embolization in hemodynamically stable patients 2
  2. Surgical management if bleeding continues despite medical management:

    • Uterine or ovarian artery ligation
    • Uterine compression sutures
    • Hysterectomy as ultimate life-saving procedure 7

Special Considerations

  • Point-of-care testing is recommended to guide blood product replacement in ongoing hemorrhage 2
  • Manual removal of placenta should not be performed except in cases of severe, uncontrollable hemorrhage 2, 1
  • Cell salvage is recommended if abnormal bleeding occurs during cesarean section (use leucocyte filter for autotransfusion) 2
  • Cumulative blood loss measurement using volumetric and gravimetric techniques is more accurate than visual estimation 2

Common Pitfalls to Avoid

  1. Delayed recognition of PPH - define as blood loss ≥500 mL after vaginal delivery or ≥1000 mL after cesarean delivery
  2. Underestimating blood loss - visual estimation is often inaccurate; use quantitative methods 2
  3. Delayed administration of tranexamic acid - must be given within 3 hours of bleeding onset 2
  4. Inappropriate use of prostaglandins in women with asthma 2
  5. Protocol-driven blood product use without laboratory guidance can lead to overtransfusion of FFP 2

Early recognition, prompt intervention with appropriate uterotonic agents, and a systematic approach to escalating care are essential to reduce morbidity and mortality from this potentially life-threatening complication.

References

Guideline

Postpartum Hemorrhage Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Postpartum haemorrhage: prevention and treatment.

Expert review of hematology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.